Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Neuroimaging for Depression [NA]
The clinical trial investigating neuroimaging for depression sponsored by Massachusetts General Hospital has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: The Study of Serum Melatonin Rhythm Levels in Patients With Major Depressive Disorder
This completed clinical trial evaluated serum melatonin rhythm levels in patients with major depressive disorder to investigate the potentia…
-
CLINICAL_TRIALS research · 2011-05-19Clinical Trial Update: ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry
Completed clinical trial registry entry for the ADH.E.R.E. mental health registry sponsored by Janssen-Cilag S.A., evaluating therapeutic ad…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression [Phase 3]
A Phase 3 trial completed evaluating risperidone as an augmentation to SSRI therapy in treatment-resistant depression. The study assessed ef…
-
FDA approval · 2011-05-17FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) by AstraZeneca Pharmaceuticals LP to update or expand the labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder. [Phase 3]
A Phase 3 study evaluating CONCERTA (methylphenidate hydrochloride) as add-on therapy for adults with major depressive disorder has complete…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder [Phase 2]
Phase 2 clinical trial evaluating desvenlafaxine succinate sustained-release tablets (DVS SR) for Major Depressive Disorder in children and …
-
FDA approval · 2011-05-12FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
FDA has approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, Inc.
-
CLINICAL_TRIALS research · 2011-05-12Clinical Trial Update: The Use of Major Depression Inventory (MDI) in Measuring Preoperative Depressive Symptoms in Breast Cancer Patients
A completed clinical trial evaluating the Major Depression Inventory as a measure of preoperative depressive symptoms in breast cancer patie…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder [Phase 3]
Phase 3 study results for desvenlafaxine succinate sustained-release in adults with major depressive disorder were posted, updating the clin…
-
FDA approval · 2011-05-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved the original ANDA for Venlafaxine hydrochloride by Dr. Reddy's Laboratories Inc, enabling a generic version of this antidepress…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD) [Phase 2]
A Phase 2 trial comparing the combination Pipamperone/Citalopram (PipCit) to Citalopram in major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Study of Transcranial Direct Current Stimulation (tDCS) to Treat Depression [Phase 2, Phase 3]
The study of transcranial direct current stimulation (tDCS) for treating depression completed Phase 2 and Phase 3 trials.
-
FDA approval · 2011-04-29FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder [Phase 3]
Pfizer reports long-term safety data from a Phase 3 trial of DVS-233 SR in adults with Major Depressive Disorder.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Treatment of Mood and Marriage Study (TOMMS) [Phase 1, Phase 2]
This clinical trial update reports the completion of the TOMMS study, a Phase 1/2 investigation into treatment for mood symptoms and partner…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent Humans [Phase 2]
Phase 2 study assessing the efficacy of sertraline augmented with gabapentin in depressed, recently abstinent individuals with cocaine use d…
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)
A completed clinical study from Ludwig-Maximilians-Universität Munich investigates transcranial direct current stimulation (tDCS) and its ef…
-
CLINICAL_TRIALS research · 2011-04-22Clinical Trial Update: Motivational and Cognitive Intervention for College Drinkers [Phase 1]
Phase 1 clinical trial evaluating a motivational and cognitive intervention to reduce alcohol consumption among college students, with concu…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Paxil CR Bioequivalence Study Brazil - Fed Administration [Phase 1]
Phase 1 bioequivalence study of Paxil CR (paroxetine controlled-release) in Brazil for depressive disorder completed; results were posted in…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With Mirtazapine [Phase 3]
Phase 3 trial comparing quetiapine XR and mirtazapine for sleep outcomes in patients with major depressive disorder; the study status is com…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder [Phase 2]
Phase 2 trial update evaluating the efficacy and tolerability of SSR125543 in outpatients with major depressive disorder has completed.
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc., authorizing a generic version of the antid…
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for venlafaxine hydrochloride, a generic antidepressant.
-
FDA approval · 2011-04-12FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.